Literature DB >> 17711502

Cellular localization and functional characterization of the equilibrative nucleoside transporters of antitumor nucleosides.

Yoshio Endo1, Tohru Obata, Daigo Murata, Mariho Ito, Kazuki Sakamoto, Masakazu Fukushima, Yasundo Yamasaki, Yuji Yamada, Nagato Natsume, Takuma Sasaki.   

Abstract

Nucleoside transporters play an important role in the disposition of nucleosides and their analogs. To elucidate the relationship between chemosensitivity to antitumor nucleosides and the functional expression of equilibrative nucleoside transporters (ENT), we established stable cell lines of human fibrosarcoma HT-1080 and gastric carcinoma TMK-1 that constitutively overexpressed green fluorescent protein-tagged hENT1, hENT2, hENT3 and hENT4. Both hENT1 and hENT2 were predictably localized to the plasma membrane, whereas hENT3 and hENT4 were localized to the intracellular organelles. The chemosensitivity of TMK-1 cells expressing hENT1 and hENT2 to cytarabine and 1-(3-C-ethynyl-beta-D-ribopentofuranosyl) cytosine increased markedly in comparison to that of mock cells. However, no remarkable changes in sensitivity to antitumor nucleosides were observed in cell lines that expressed both hENT3 and hENT4. These data suggest that hENT3 and hENT4, which are mainly located in the intracellular organelles, are not prominent nucleoside transporters like hENT1 and hENT2, which are responsible for antitumor nucleoside uptake.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17711502     DOI: 10.1111/j.1349-7006.2007.00581.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  13 in total

1.  Dipyridamole analogs as pharmacological inhibitors of equilibrative nucleoside transporters. Identification of novel potent and selective inhibitors of the adenosine transporter function of human equilibrative nucleoside transporter 4 (hENT4).

Authors:  Chunmei Wang; Wenwei Lin; Hilaire Playa; Shan Sun; Keyuna Cameron; John K Buolamwini
Journal:  Biochem Pharmacol       Date:  2013-09-07       Impact factor: 5.858

2.  Novel nuclear hENT2 isoforms regulate cell cycle progression via controlling nucleoside transport and nuclear reservoir.

Authors:  Natalia Grañé-Boladeras; Christopher M Spring; W J Brad Hanna; Marçal Pastor-Anglada; Imogen R Coe
Journal:  Cell Mol Life Sci       Date:  2016-06-06       Impact factor: 9.261

3.  Phosphate-responsive signaling pathway is a novel component of NAD+ metabolism in Saccharomyces cerevisiae.

Authors:  Shu-Ping Lu; Su-Ju Lin
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

Review 4.  Contribution of tumoral and host solute carriers to clinical drug response.

Authors:  Jason A Sprowl; Torben S Mikkelsen; Hugh Giovinazzo; Alex Sparreboom
Journal:  Drug Resist Updat       Date:  2012-03-28       Impact factor: 18.500

5.  OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues.

Authors:  Christina D Drenberg; Alice A Gibson; Stanley B Pounds; Lei Shi; Dena P Rhinehart; Lie Li; Shuiying Hu; Guoqing Du; Anne T Nies; Matthias Schwab; Navjotsingh Pabla; William Blum; Tanja A Gruber; Sharyn D Baker; Alex Sparreboom
Journal:  Cancer Res       Date:  2017-02-16       Impact factor: 12.701

Review 6.  Regulation of NAD+ metabolism, signaling and compartmentalization in the yeast Saccharomyces cerevisiae.

Authors:  Michiko Kato; Su-Ju Lin
Journal:  DNA Repair (Amst)       Date:  2014-08-02

7.  Less is more: Nutrient limitation induces cross-talk of nutrient sensing pathways with NAD+ homeostasis and contributes to longevity.

Authors:  Felicia Tsang; Su-Ju Lin
Journal:  Front Biol (Beijing)       Date:  2015-07-30

8.  Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients.

Authors:  Giovanni Brandi; Marzia Deserti; Francesco Vasuri; Andrea Farioli; Alessio Degiovanni; Andrea Palloni; Giorgio Frega; Maria A Barbera; Stefania de Lorenzo; Ingrid Garajova; Mariacristina Di Marco; Antonio D Pinna; Matteo Cescon; Alessandro Cucchetti; Giorgio Ercolani; Antonietta D'Errico-Grigioni; Maria A Pantaleo; Guido Biasco; Simona Tavolari
Journal:  Oncologist       Date:  2016-03-31

Review 9.  Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets.

Authors:  Marçal Pastor-Anglada; Sandra Pérez-Torras
Journal:  Front Pharmacol       Date:  2015-02-10       Impact factor: 5.810

10.  Emerging Roles of Nucleoside Transporters.

Authors:  Marçal Pastor-Anglada; Sandra Pérez-Torras
Journal:  Front Pharmacol       Date:  2018-06-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.